Related content

Chemokines as Therapeutic Targets in Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 3, 2002-01 ,pp. : 403-417

Bentham Science Publishers

Access to resources Recommend Favorite

Combined inhibition of insulin-like growth factor-1 receptor enhances the effects of gefitinib in a human non-small cell lung cancer resistant cell line

By Qi Hui wei   Shen Zan   Fan Li hong  

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-11 ,pp. : 1091-1095

Spandidos Publications

Access to resources Recommend Favorite

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 6, 2013-01 ,pp. : 1943-1947

Spandidos Publications

Access to resources Recommend Favorite

A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis

By        

Oncology Letters, Vol. 4, Iss. 5, 2012-01 ,pp. : 1109-1113

Spandidos Publications

Access to resources Recommend Favorite

Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo

By      

Oncology Reports, Vol. 31, Iss. 4, 2014-01 ,pp. : 1954-1960

Spandidos Publications

Access to resources Recommend Favorite